Past studies have demonstrated that the activation of TLR4 signaling generates proinflammatory cytokines and antiapoptotic proteins, which in turn contributes to the growth, metastasis, and chemoresistance in ovarian cancer [7, 8]. The gene discussed is TLR4; the disease is ovarian cancer.